A Multi-center Evaluation of Aldafermin in a Randomized, Double-blind, Placebo-controlled Study in Subjects with Primary Sclerosing Cholangitis.

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
A multi-center evaluation of aldafermin in a randomized, double-blind, placebo-controlled study in subjects with Primary Sclerosing Cholangitis.
Epistemonikos ID: 067ba561d39c779ab77c2cb9c973f170c4caa1c9
First added on: Oct 24, 2024